Saturday 17 October 2026
Export QSI’s income statement to Excel — free account
Quantum-Si Incorporated
QSI Healthcare Medical Devices
Quantum-Si Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.4 million, down 20.3% from fiscal 2024. In the quarter to June 2026, revenue fell 41.8%, EPS grew 31.3% and free cash flow grew 9.75%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
1.12
0.19
−14.50%
Follow QSI
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | 9.88 | 5.33 | 1.72 | 1.12 | 0.61 | 0.95 |
Analyst estimates 2026–2028 Powerpack |
|||
| High | — | — | — | — | 11.88 | 25.00 | 8.31 | 3.90 | 4.14 | 5.77 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | 2 | 153 | 196 | 159 | 143 | 145 | ||||
| Revenue/emp, $m | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | — | — | 1 | 3 | 2 | ||||
| Gross margin, % | — | — | — | — | 0.00 | 0.00 | 0.00 | 45.10 | 52.32 | 47.33 | |||||
| EBT | — | — | — | (36) | (37) | (95) | (132) | (96) | (101) | (101) | |||||
| EBT margin, % | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | (8,868.76) | (3,301.21) | (4,157.68) | |||||
| Net income | — | 0 | — | (36) | (37) | (95) | (132) | (96) | (101) | (101) | |||||
| Depreciation | — | — | — | 1 | 1 | 1 | 12 | 4 | (4) | (4) | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.01 | ||||
| Earnings | — | — | — | (6.95) | (6.84) | (1.19) | (0.95) | (0.68) | (0.71) | (0.51) | |||||
| Cash flow | — | — | — | (5.97) | (6.08) | (0.84) | (0.65) | (0.67) | (0.61) | (0.48) | |||||
| Capex | — | — | — | (0.24) | (0.09) | (0.07) | (0.08) | (0.04) | (0.03) | (0.01) | |||||
| Free cash flow | — | — | — | (6.21) | (6.17) | (0.91) | (0.73) | (0.70) | (0.65) | (0.49) | |||||
| Book value | — | — | — | 0.00 | (29.82) | 5.99 | 2.58 | 1.92 | 1.50 | 1.11 | |||||
| Shares, m | — | — | — | 5 | 5 | 80 | 139 | 141 | 143 | 198 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | — | — | 265.10 | 126.43 | 89.30 | |||||
| P/B | — | — | — | — | — | — | — | 1.06 | 1.79 | 0.99 | |||||
| EV/Sales | — | — | — | — | — | — | — | 26.90 | 57.89 | 22.43 | |||||
| EV/FCF | — | — | — | — | — | — | — | (0.29) | (1.92) | (0.56) | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | (31) | (33) | (67) | (91) | (94) | (88) | (95) | ||||
| Capex | — | — | — | (1) | 0 | (6) | (11) | (5) | (5) | (3) | |||||
| Free cash flow | — | — | — | (32) | (33) | (73) | (101) | (99) | (92) | (97) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | 35 | 466 | 342 | 255 | 200 | 153 | ||||
| Total debt | — | — | — | — | 2 | 7 | 16 | — | — | — | |||||
| Net debt | — | — | — | — | (35) | (471) | (351) | (258) | (210) | (163) | |||||
| Shareholders’ equity | — | — | — | — | (160) | 477 | 359 | 272 | 215 | 220 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | 0.00 | (180.40) | (34.93) | (29.61) | (27.83) | (36.99) | (41.07) | ||||
| ROIC | — | — | — | 0.00 | 0.00 | (1,057.02) | (1,046.38) | (500.48) | (1,166.58) | (126.60) | |||||
| ROE | — | — | — | 0.00 | (23.08) | (59.87) | (31.69) | (30.45) | (41.48) | (46.52) | |||||
Negative figures in brackets.
Fiscal years to Dec 2025 · latest quarter Jun 2026
Charts ten years each
Quantum-Si Incorporated vs peers in Medical Devices (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| CV CapsoVision, Inc. | $343.2M | 2.1× | — (loss-making) | +9.89% (above 0%: growing) | n/m | −84.44% (below 0%: shrinking) | 51.36% | (208.07%) | Compare |
| RCEL Avita Medical Inc. | $333.1M | — (loss-making) | — (loss-making) | +17.83% (above 0%: growing) | n/m | +66.52% (above 0%: growing) | 81.87% | (28.42%) | Compare |
| CLPT ClearPoint Neuro, Inc. | $294.1M | — (loss-making) | — (loss-making) | +18.07% (above 0%: growing) | n/m | −173.51% (below 0%: shrinking) | 61.67% | (94.15%) | Compare |
| QSI Quantum-Si Incorporated | $286.7M | — (loss-making) | — (loss-making) | −41.79% (below 0%: shrinking) | n/m | +9.75% (above 0%: growing) | 50.00% | (7,450.29%) | |
| INFU InfuSystems Holdings, Inc. | $277.2M | 31.7× | 21.7× | +2.59% (above 0%: growing) | +33.33% (above 0%: growing) | −66.54% (below 0%: shrinking) | 57.98% | 11.24% | Compare |
| TMCI Treace Medical Concepts, Inc. | $267.9M | — (loss-making) | — (loss-making) | −4.24% (below 0%: shrinking) | n/m | +11.74% (above 0%: growing) | 78.47% | (32.96%) | Compare |
| CATX Perspective Therapeutics, Inc. | $267.1M | — (loss-making) | — (loss-making) | −72.07% (below 0%: shrinking) | n/m | −66.09% (below 0%: shrinking) | 100.00% | (36,120.99%) | Compare |
| LAB Standard BioTools Inc. | $258.5M | 2.9× | — (loss-making) | −7.62% (below 0%: shrinking) | n/m | +52.76% (above 0%: growing) | 52.40% | (126.28%) | Compare |
| TLSI TriSalus Life Sciences, Inc. | $240.1M | — (loss-making) | — (loss-making) | +1.73% (above 0%: growing) | n/m | −41.29% (below 0%: shrinking) | 86.78% | (86.03%) | Compare |
| Median of peers | $272.6M | 2.9× | — | +2.16% | — | −53.69% | 70.07% | (90.09%) |
Quantum-Si Incorporated (QSI) key facts
- Concern: Quantum-Si Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.4 million, down 20.3% from fiscal 2024.
- Quantum-Si Incorporated (QSI) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
- As of October 16, 2026, QSI traded at $1.12, a market capitalization of $286.7 million.
- Return on equity was −46.5% and debt-to-equity 0.00.
- Its Piotroski F-score is 2 out of 9 and its Altman Z-score is 0.36 (distress zone) for fiscal 2025.
Quantum-Si Incorporated (QSI) Latest News
No news at this impact. Lower the threshold for more.